JPMorgan Chase & Co’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Sell |
591,841
-62,542
| -10% | -$162K | ﹤0.01% | 3498 |
|
|
2025
Q1 | $4.4M | Sell |
654,383
-114,047
| -15% | -$768K | ﹤0.01% | 2753 |
|
|
2024
Q4 | $5.22M | Sell |
768,430
-287,092
| -27% | -$1.95M | ﹤0.01% | 2717 |
|
|
2024
Q3 | $8.75M | Buy |
1,055,522
+25,002
| +2% | +$207K | ﹤0.01% | 2244 |
|
|
2024
Q2 | $6.53M | Buy |
1,030,520
+765,945
| +290% | +$4.86M | ﹤0.01% | 2372 |
|
|
2024
Q1 | $2.45M | Buy |
264,575
+212,312
| +406% | +$1.97M | ﹤0.01% | 3027 |
|
|
2023
Q4 | $666K | Buy |
52,263
+26,831
| +106% | +$342K | ﹤0.01% | 3757 |
|
|
2023
Q3 | $263K | Sell |
25,432
-3,988
| -14% | -$41.2K | ﹤0.01% | 4076 |
|
|
2023
Q2 | $386K | Sell |
29,420
-118,798
| -80% | -$1.56M | ﹤0.01% | 3904 |
|
|
2023
Q1 | $1.66M | Buy |
148,218
+90,404
| +156% | +$1.01M | ﹤0.01% | 3148 |
|
|
2022
Q4 | $487K | Buy |
57,814
+25,051
| +76% | +$211K | ﹤0.01% | 3771 |
|
|
2022
Q3 | $545K | Buy |
32,763
+1,026
| +3% | +$17.1K | ﹤0.01% | 3690 |
|
|
2022
Q2 | $467K | Buy |
31,737
+4,927
| +18% | +$72.5K | ﹤0.01% | 3918 |
|
|
2022
Q1 | $665K | Sell |
26,810
-24,794
| -48% | -$615K | ﹤0.01% | 3842 |
|
|
2021
Q4 | $1.66M | Sell |
51,604
-107,589
| -68% | -$3.45M | ﹤0.01% | 3342 |
|
|
2021
Q3 | $5.73M | Buy |
159,193
+146,960
| +1,201% | +$5.29M | ﹤0.01% | 2491 |
|
|
2021
Q2 | $540K | Sell |
12,233
-102,318
| -89% | -$4.52M | ﹤0.01% | 3945 |
|
|
2021
Q1 | $5.24M | Buy |
114,551
+86,886
| +314% | +$3.97M | ﹤0.01% | 2614 |
|
|
2020
Q4 | $1.91M | Buy |
+27,665
| New | +$1.91M | ﹤0.01% | 2989 |
|